Mild nutrient starvation triggers the development of a small-cell survival morphotype in mycobacteria

by Wu, M.-L, Gengenbacher, M, Dick, T
Published 2020

Reduced drug uptake in phenotypically resistant nutrient-starved nonreplicating Mycobacterium tuberculosis

by Sarathy, J., Dartois, V., Dick, T., Gengenbacher, M.
Published 2014

Draft genome sequence of Mycobacterium abscessus Bamboo

by Yee, M, Klinzing, D, Wei, J.-R, Gengenbacher, M, Rubin, E.J, Dick, T
Published 2020

The tuberculosis vaccine candidate bacillus Calmette-Guérin ?ureC

by Rao M., Vogelzang A., Kaiser P., Schuerer S., Kaufmann S.H.E., Gengenbacher M.
Published 2020

Rifabutin Is active against mycobacterium abscessus complex

by Aziz, D.B, Low, J.L, Wu, M.-L, Gengenbacher, M, Teo, J.W.P, Dartois, V, Dick, T
Published 2020

Developmental transcriptome of resting cell formation in Mycobacterium smegmatis

by Wu M.-L., Gengenbacher M., Chung J.C.S., Chen S.L., Mollenkopf H.-J., Kaufmann S.H.E., Dick T.
Published 2018

Draft genome sequence of Mycobacterium avium 11

by Yee, M, Klinzing, D, Wei, J.-R, Gengenbacher, M, Rubin, E.J, Chien, J.-Y, Hsueh, P.-R, Dick, T
Published 2020

Pyrazinamide resistance is caused by two distinct mechanisms: Prevention of coenzyme a depletion and loss of virulence factor synthesis

by Gopal, P, Yee, M, Sarathy, J, Liang Low, J, Sarathy, J.P, Kaya, F, Dartois, V, Gengenbacher, M, Dick, T
Published 2020

Whole-cell screen of fragment library identifies gut microbiota metabolite indole propionic acid as antitubercular

by Negatu, D.A, Liu, J.J.J, Zimmerman, M, Kaya, F, Dartois, V, Aldrich, C.C, Gengenbacher, M, Dicka, T
Published 2020

Gut microbiota metabolite indole propionic acid targets tryptophan biosynthesis in Mycobacterium tuberculosis

by Negatu, D.A., Yamada, Y., Xi, Y., Go, M.L., Zimmerman, M., Ganapathy, U., Dartois, V., Gengenbacher, M., Dick, T.
Published 2022

The mycobacterial membrane: A novel target space for anti-tubercular drugs

by Chen H., Nyantakyi S.A., Li M., Gopal P., Aziz D.B., Yang T., Moreira W., Gengenbacher M., Dick T., Go M.L.
Published 2019

Deletion of nuoG from the vaccine candidate Mycobacterium bovis BCG ΔureC:: Hly improves protection against tuberculosis

by Gengenbacher, M, Nieuwenhuizen, N, Vogelzang, A, Liu, H, Kaiser, P, Schuerer, S, Lazar, D, Wagner, I, Mollenkopf, H.-J, Kaufmann, S.H.E
Published 2020

Antigen 85C inhibition restricts Mycobacterium tuberculosis growth through disruption of cord factor biosynthesis

by Warrier, T, Tropis, M, Werngren, J, Diehl, A, Gengenbacher, M, Schlegel, B, Schade, M, Oschkinat, H, Daffe, M, Hoffner, S, Eddine, A.N, Kaufmann, S.H.E
Published 2020

NOS2-deficient mice with hypoxic necrotizing lung lesions predict outcomes of tuberculosis chemotherapy in humans

by Gengenbacher, M, Duque-Correa, M.A, Kaiser, P, Schuerer, S, Lazar, D, Zedler, U, Reece, S.T, Nayyar, A, Cole, S.T, Makarov, V, Barry, C.E, Dartois, V, Kaufmann, S.H.E
Published 2020

Pyrazinamide triggers degradation of its target aspartate decarboxylase

by Gopal, P., Sarathy, J.P., Yee, M., Ragunathan, P., Shin, J., Bhushan, S., Zhu, J., Akopian, T., Kandror, O., Lim, T.K., Gengenbacher, M., Lin, Q., Rubin, E.J., Grüber, G., Dick, T.
Published 2021

Impact of immunopathology on the antituberculous activity of pyrazinamide

by Blanc, L, Sarathy, J.P, Cabrera, N.A, O’Brien, P, Dias Freedman, I, Mina, M, Sacchettini, J, Savic, R.M, Gengenbacher, M, Podell, B.K, Prideaux, B, Ioerger, T, Dick, T, Dartois, V
Published 2020